Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

New and emerging immune-targeted drugs for the treatment of multiple sclerosis.
IL-21 and IL-21 receptor in the immunopathogenesis of multiple sclerosis.
Therapeutic inhibition of the alternative complement pathway attenuates chronic EAE.
S1P1 receptor subtype inhibits demyelination and regulates chemokine release in cerebellar slice cultures.
Comparison between balanced steady-state free precession and standard spoiled gradient echo magnetization transfer ratio imaging in multiple sclerosis: methodical and clinical considerations.
Iron chelation and multiple sclerosis.
Bone health in chronic neurological diseases: a focus on multiple sclerosis and parkinsonian syndromes.
Increased thyroid autoimmunity among women with multiple sclerosis in the postpartum setting.
Regulation of human glia by multiple sclerosis disease modifying therapies.
Diverting T helper cell trafficking through increased plasticity attenuates autoimmune encephalomyelitis.
Female sex steroids and glia cells: Impact on multiple sclerosis lesion formation and fine tuning of the local neurodegenerative cellular network.
Teriflunomide and its mechanism of action in multiple sclerosis.
Disparate Effects of Mesenchymal Stem Cells in Experimental Autoimmune Encephalomyelitis and Cuprizone-Induced Demyelination.
Consequences of perinatal bisphenol A exposure in a mouse model of multiple sclerosis.
Emerging roles of system [Formula: see text] antiporter and its inhibition in CNS disorders.
Mast cells in the pathogenesis of multiple sclerosis and experimental autoimmune encephalomyelitis.
Interferon Beta and vitamin d synergize to induce immunoregulatory receptors on peripheral blood monocytes of multiple sclerosis patients.
Automated detection of white matter and cortical lesions in early stages of multiple sclerosis.
Pivotal role of choline metabolites in remyelination.
Regulation of oligodendrocyte precursor migration during development, in adulthood and in pathology.
PML: The Dark Side of Immunotherapy in Multiple Sclerosis.
Item response theory-based measure of global disability in multiple sclerosis derived from the Performance Scales and related items.
Life on hold: the experience of living with neuromyelitis optica.
Exploring potential mechanisms of action of natalizumab in secondary progressive multiple sclerosis.
Fingolimod for the treatment of relapsing multiple sclerosis.

Pages